Drug Database
Back to search

Belgium· BE-AMP-SAM257774-00

Avandamet 1 mg - 500 mg

A metformin and rosiglitazone product containing metformin hydrochloride, registered in Belgium by Smithkline Beecham Pharmaceuticals. The same ATC class is registered in 4 of our 19 countries.

ATC A10BD03

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedAvandamet 1 mg - 500 mgATCA10BD03REGISTER NO.BE-AMP-SAM257774-00PACKS LISTED0CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about metformin hydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Metformin and rosiglitazone is registered in 4 of 19 countries.

Countries holding a registration under ATC A10BD03 (metformin and rosiglitazone), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 2 of them publish a price we can compare per daily dose
Search metformin and rosiglitazone products by name

Metformin and rosiglitazone · ATC A10BD03

4 / 19 countries

  • Belgiumprice
  • Denmark
  • Finlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Metformin Hydrochloride
Manufacturer
Smithkline Beecham Pharmaceuticals
Country
Belgium (BE)
ATC code
A10BD03
ATC class
Metformin and rosiglitazone
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

3 interactions on record for metformin and rosiglitazone.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check metformin and rosiglitazone against other medicinesHow interaction checks work

Metformin and rosiglitazone · interactions on record

3 records

3 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Metformin and rosiglitazone in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All metformin and rosiglitazone products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Diabetex, Glucophage
  • Bulgaria · Meglucon Xr, Metformin Interdos Pharma
  • Cyprus · Brotmin, Glucophage
  • Czechia · Brotmin, Glucomet
  • Germany · Glucophage, Juformin
  • Denmark · Forminet, Lyomet
  • Estonia · Brotmin, Diabufor Xr
  • Spain · Brotmin, Dianben
  • Finland · Forminet, Glucophage
  • France · Glimezit, Glucophage
  • United Kingdom (Northern Ireland) · Abiano, Axpinet
  • Greece · Glucoformin, Glucofree
  • Croatia · Aglurab, Belformin
  • Hungary · Adimet, Adimet Xr
  • Ireland · Glucophage, Metformin Accord
  • Iceland · Forminet, Glucophage
  • Italy · Glucophage, Glucophage Unidie
  • Lithuania · Brotmin, Metfogamma
  • Luxembourg · Glucophage, Metformax
  • Latvia · Brotmin, Glucient Sr
  • Malta · Brotmin, Glyformin
  • Netherlands · Glucient Sr, Glycofren
  • Norway · Forminet, Glucophage
  • Poland · Abmetfina Xr, Avamina
  • Portugal · Allmet, Glucophage
  • Romania · Brotmin, Glucophage
  • Sweden · Forminet, Glucophage
  • Slovenia · Aglurab, Glucophage
  • Slovakia · Glucophage, Glucophage Xr

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/5e0bfe1c-44bc-4163-acc4-23f7d4b2bc97
GET /v1/drugs/5e0bfe1c-44bc-4163-acc4-23f7d4b2bc97?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Avandamet 1 mg - 500 mg",
  "name_fr": "Avandamet 1 mg - 500 mg",
  "name_nl": "Avandamet 1 mg - 500 mg",
  "amp_code": "SAM257774-00",
  "strengths": [
    "500.0000",
    "390.0000",
    "1.0000"
  ],
  "pack_count": 5,
  "substances": [
    "Metformin Hydrochloride",
    "Metformin",
    "Rosiglitazone Maleate",
    "Rosiglitazone"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Metformin and Rosiglitazone",
  "authorisation_numbers": [
    "EU/1/03/258/015",
    "EU/1/03/258/019"
  ]
}
API referenceMCP serverPlans

See everything about metformin and rosiglitazone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console